Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 33,439 | 21,619 | 20,654 | 18,707 | 24,104 |
| Cost of Goods | 5,369 | 4,248 | 3,944 | 3,327 | 5,085 |
| Gross Profit | 28,070 | 17,371 | 16,710 | 15,380 | 19,019 |
| Operating Expenses | 34,036 | 23,079 | 21,705 | 17,109 | 15,469 |
| Operating Income | -5,597 | -5,460 | -4,051 | -1,402 | 3,635 |
| Interest Expense | 1,028 | 963 | 1,038 | 1,031 | 1,070 |
| Other Income | 6 | 5 | 6 | 1 | 2 |
| Pre-tax Income | -6,619 | -6,418 | -5,083 | -2,432 | 2,567 |
| Net Income Continuous | -6,619 | -6,418 | -5,083 | -2,432 | 2,567 |
| Net Income | $-6,619 | $-6,418 | $-5,083 | $-2,432 | $2,567 |
| EPS Basic Total Ops | -0.14 | -0.12 | -0.10 | -0.07 | 0.07 |
| EPS Basic Continuous Ops | -0.14 | -0.12 | -0.10 | -0.06 | 0.07 |
| EPS Diluted Total Ops | -0.14 | -0.12 | -0.10 | -0.07 | 0.07 |
| EPS Diluted Continuous Ops | -0.14 | -0.12 | -0.10 | -0.06 | 0.07 |
| EBITDA(a) | $-5,278 | $-5,226 | $-3,903 | $-1,242 | $3,895 |